MAPT and neurodegenerative disease: In contrast to the acute injury phase, during the later injury phase, the bulk of the neurodegenerative disease associated protein variants had been cleared from the brain, except for two specific protein variants, the C6T Aβ variant and the F9T tau variant, which accounted for all of the significant correlations between subacute behavioral deficits and protein variant levels.